La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su del período menstrual debe suspenderse el fármaco y confirmar el embarazo. Publisher: Cabergolina y bromocriptina son los fármacos más utilizados probablemente aumenta la probabilidad de embarazo, y se asocia a. El uso de cabergolina no afecta el resultado de embarazo (tasa de embarazo clínico, tasa de aborto espontáneo), ni existe un aumento en el riesgo de eventos .

Author: Ganris Meztizilkree
Country: Luxembourg
Language: English (Spanish)
Genre: Music
Published (Last): 28 September 2016
Pages: 79
PDF File Size: 10.28 Mb
ePub File Size: 3.50 Mb
ISBN: 333-1-67270-280-6
Downloads: 22592
Price: Free* [*Free Regsitration Required]
Uploader: Mikar

Cabergoline or bromocriptine for prolactinoma?. In general, it is recommended that fetal exposure to all drugs be limited to as short a period as possible. Primary medical therapy of micro- and macroprolactinomas in men.

Comparative effects of bromocriptine and cabergoline on serum prolactin levels, liver and kidney function tests in hyperprolactinemic women. In the absence of menstrual period, the drug should be discontinued and confirm pregnancy. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: Indian J Med Res. We combined the evidence using meta-analysis and generated a summary of findings following the GRADE approach.

Sobre los desenlaces incluidos cabergokina este resumen.

La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su excelente tolerabilidad y prolongada vida media. Both, bromocriptine and cabergoline, showed no evidence of obstetric and neonatal complications; however, experience with bromocriptine is higher. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea.


Cabergolina: MedlinePlus medicinas

Cabergoline currently suggested rather than bromocriptine due to their excellent tolerability and long half-life. Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: Osteocalcin levels in patients with microprolactinoma before and during medical treatment. Pakistan Journal of Medical Sciences Online. The prolactinomas are the most common functioning pituitary tumors.

Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified two systematic reviews including 12 studies addressing the question of this article, including five randomized controlled trials. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: La bromocriptina se asocia a mayores efectos adversos que cabergolina.

Dostinex y embarazo múltiple

Diagnosis and treatment of yperprolactinemia: In microprolactinomas the ophthalmologic examination is no formal indication. De los estudios no aleatorizados incluidos, los tres corresponden a cohortes retrospectivas.

N Engl J Med. The hyperprolactinemia is associated cabergooina anovulation and infertility. Medwave se preocupa por su privacidad y la seguridad de sus datos personales. Hay evidencia de que la lactancia materna no presenta mayor riesgo para el crecimiento tumoral.

[Update on endocrinology: management of prolactinomas during pregnancy].

Por lo tanto, parte de la evidencia incluida en este resumen no fue considerada. Results of a national multicenter randomized double-blind study]. However, it is not clear if this translates into clinical benefits. Cabergoline is a long-acting dopamine receptor agonist which might offer advantages over bromocriptine.

Cabergolina y embarazo semanas

Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing Cabdrgolina. Cabergolina versus bromocriptina para la hiperprolactinemia o prolactinoma. Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea. Todos los estudios compararon bromocriptina versus cabergolina.


Cabergoline and bromocriptine are among the most commonly used drugs to treat prolactinoma. Su principal desarrollo es la base de datos Epistemonikos www. The patients with macroprolactinomas should be monitored clinically and evaluate the symptoms related to cabergokina tumor size. If growth in the adenoma is suspected, nuclear magnetic resonance and neuro-ophthalmologic examination should be performed.

Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.

It is not clear whether cabergoline is also more effective with respect to tumor growth because the certainty of the evidence is very low. Para un estudio no se especifican dosis de cabergolina y bromocriptina en ninguna de las revisiones identificadas [11]. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.

There is evidence that breastfeeding no increased risk for tumor growth. J Embarazi Endocrinol Metab.

Cabergoline Comparative Study Group. Middle East Fertility Society Journal.